Provided by Tiger Fintech (Singapore) Pte. Ltd.

Jaguar Animal Health

2.80
+0.02000.72%
Post-market: 2.850.0500+1.79%19:53 EDT
Volume:87.10K
Turnover:245.59K
Market Cap:3.54M
PE:-0.02
High:2.95
Open:2.95
Low:2.74
Close:2.78
Loading ...

Jaguar Health files to sell 507.4K shares of common stock for holders

TIPRANKS
·
Yesterday

Jaguar Health Inc. to Present at the Emerging Growth Conference for Updates on Near-Term Catalysts

Reuters
·
17 Jun

Jaguar Health Inc. Establishes First Study Site for Canalevia-CA1 Field Study Amid Ongoing FDA Review for Expanded Canine Diarrhea Treatment Approval

Reuters
·
11 Jun

Jaguar Health Pursues FDA Orphan Drug Designation and Expanded Access for Crofelemer in Metastatic Breast Cancer Treatment

Reuters
·
09 Jun

Jaguar Health Inc. to Participate in Virtual Fireside Chat at Lytham Partners' Spring 2025 Spotlight Series

Reuters
·
06 Jun

Jaguar Health Inc. Releases Investor Presentation Highlighting Operational Strategies and Financial Overview

Reuters
·
27 May

Jaguar Health Prices Offering of Shares, Warrants

MT Newswires Live
·
21 May

Jaguar Health prices 246,306 shares at $6.09 in registered direct offering

TIPRANKS
·
21 May

Jaguar Health Inc. Announces $1.5 Million Registered Direct Offering, Issuing 246,306 Shares at $6.09 Each

Reuters
·
21 May

Jaguar Health announces first patient randomized in crofelemer trial

TIPRANKS
·
20 May

Jaguar Health Inc. Launches Phase 2 Clinical Trial for Crofelemer in Pediatric MVID Patients

Reuters
·
20 May

Jaguar Health Initiated at Buy by First Berlin

Dow Jones
·
19 May

Jaguar Animal Health: Mixed Sentiments in Latest Earnings Call

TIPRANKS
·
17 May

Jaguar Health Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
17 May

Jaguar Health Q1 EPS $(16.70) Beats $(18.00) Estimate, Sales $2.21M Miss $2.82M Estimate

Benzinga
·
16 May

Jaguar Health Reports 37% Drop in Q1 2025 Revenue, Net Loss Widens by 13%, EPS Improves by 81%

Reuters
·
16 May

Jaguar Health Q1 Basic EPS USD -16.7

THOMSON REUTERS
·
16 May

Jaguar Health Q1 Adjusted Ebitda USD -9.74 Million

THOMSON REUTERS
·
16 May

Jaguar Health Inc. Releases Presentation on Plant-Based Medicines for Gastrointestinal Disorders

Reuters
·
14 May

Jaguar Health Inc expected to post a loss of $18.00 a share - Earnings Preview

Reuters
·
09 May